Statin-induced rhabdomyolysis is a frequent complication in renal transplant recipients
receiving cyclosporine, but incidences are different between different types of statins. Statins …

Objective To discuss the pathogenesis of the statin-induced rhabdomyolysis in renal
transplant recipients. Methods We presented two renal transplant recipients who developed …

Discussion. Rhabdomyolysis is an important but uncommon side effect of statins. Only one
case was recorded in the 4S trial and none in WOSCOPS, AFCAPS, LIPID and CARE. With …

OBJECTIVE: To report a severe interaction between simvastatin and rapamycin resulting in
rhabdomyolysis and acute renal failure in a liver transplant patient. BACKGROUND: A 56 …

Background: Cardiovascular disease is the most common cause of morbidity and mortality
among longterm renal transplant recipients, and hyperlipidemia is an important risk factor for …

OBJECTIVE: To describe a case of rhabdomyolysis in a cadaveric renal transplant (CRT)
patient receiving atorvastatin and cyclosporine. CASE SUMMARY: A 40-year-old Asian …

Background This study aimed to describe a case of rhabdomyolysis and acute kidney injury
potentiated by a drug-drug interaction (DDI) between cyclosporine, leflunomide, and …

Background. There are several case reports of rhabdomyolysis (RM) in renal transplant
recipients, but the actual incidence of this complication is not known. Most of the reported …

Background. Statins are widely used to decrease cholesterol and improve morbidity and
mortality associated with coronary artery disease. Myopathy constitutes a rare but potentially …

= Rhabdomyolysis in a Cyclosporine-treated Renal Transplant Recipient Who Received
Atorvastatin asReplacement for FluvastatinWan Bok Lee, MD, Jin Woo Park, MD Min Soo …